UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 871

Sortiert nach

KRAS Mutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer

Clinical cancer research, 2007-05, Vol.13 (10), p.2890-2896

2007

Link zum Volltext

Verfügbarkeit prüfen

Epidermal Growth Factor Receptor Copy Number Alterations Correlate With Poor Clinical Outcome in Patients With Head and Neck Squamous Cancer

Journal of clinical oncology, 2007-06, Vol.25 (16), p.2164-2170

2007

Link zum Volltext

Verfügbarkeit prüfen

Response to Neoadjuvant Systemic Therapy for Breast Cancer in BRCA Mutation Carriers and Noncarriers: A Single-Institution Experience

Journal of clinical oncology, 2011-10, Vol.29 (28), p.3739-3746

2011

Link zum Volltext

Verfügbarkeit prüfen

EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy

PloS one, 2020, Vol.15 (3), p.e0229903-e0229903

2020

Link zum Volltext

Verfügbarkeit prüfen

ETS2 Mediated Tumor Suppressive Function and MET Oncogene Inhibition in Human Non―Small Cell Lung Cancer

Clinical cancer research, 2013-07, Vol.19 (13), p.3383-3395

2013

Link zum Volltext

Verfügbarkeit prüfen

Adding Erlotinib to Chemoradiation Improves Overall Survival but Not Progression-Free Survival in Stage III Non-Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2015-06, Vol.92 (2), p.317-324

2015

Link zum Volltext

Verfügbarkeit prüfen

miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1

Molecular cancer research, 2011-01, Vol.9 (1), p.25-35

2011

Link zum Volltext

Verfügbarkeit prüfen

Nomogram to Predict the Benefit of Radiation for Older Patients With Breast Cancer Treated With Conservative Surgery

Journal of clinical oncology, 2012-08, Vol.30 (23), p.2837-2843

2012

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of talimogene laherparepvec for patients with inoperable locoregional recurrence of breast cancer

Scientific reports, 2021-11, Vol.11 (1), p.22242-8, Article 22242

2021

Link zum Volltext

Verfügbarkeit prüfen

Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung

Modern pathology, 2009-05, Vol.22 (5), p.668-678

2009

Link zum Volltext

Verfügbarkeit prüfen

Frequency of Sarcopenia, Sarcopenic Obesity, and Changes in Physical Function in Surgical Oncology Patients Referred for Prehabilitation

Integrative cancer therapies, 2021, Vol.20, p.15347354211000118-15347354211000118

2021

Link zum Volltext

Verfügbarkeit prüfen

Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer

The Annals of thoracic surgery, 2018-02, Vol.105 (2), p.418-424

2018

Link zum Volltext

Verfügbarkeit prüfen

Could Objective Tests Be Used to Measure Fatigue in Patients with Advanced Cancer?

Journal of pain and symptom management, 2017-08, Vol.54 (2), p.237-244

2017

Link zum Volltext

Verfügbarkeit prüfen

A predictive probability design for phase II cancer clinical trials

Clinical trials (London, England), 2008-01, Vol.5 (2), p.93-106

2008

Link zum Volltext

Verfügbarkeit prüfen

Patients' Perspective of Timeliness and Usefulness of an Outpatient Supportive Care Referral at a Comprehensive Cancer Center

Journal of pain and symptom management, 2019-08, Vol.58 (2), p.275-281

2019

Link zum Volltext

Verfügbarkeit prüfen

Abnormalities of the TITF-1 Lineage-Specific Oncogene in NSCLC: Implications in Lung Cancer Pathogenesis and Prognosis

Clinical cancer research, 2011-04, Vol.17 (8), p.2434-2443

2011

Link zum Volltext

Verfügbarkeit prüfen

CoxPhLb: An R Package for Analyzing Length Biased Data under Cox Model

The R journal, 2020-06, Vol.12 (1), p.118-130

2020

Link zum Volltext

Verfügbarkeit prüfen

Perioperative beta-blocker use and survival in lung cancer patients

Journal of clinical anesthesia, 2014-03, Vol.26 (2), p.106-117

2014

Link zum Volltext

Verfügbarkeit prüfen

Lack of PTEN Expression in Non-Small Cell Lung Cancer Could Be Related to Promoter Methylation

Clinical cancer research, 2002-05, Vol.8 (5), p.1178-1184

2002

Link zum Volltext

Verfügbarkeit prüfen

Bayesian clinical trials at the University of Texas M. D. Anderson Cancer Center

Clinical trials (London, England), 2009-06, Vol.6 (3), p.205-216

2009

Link zum Volltext

Verfügbarkeit prüfen

Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinoma

PloS one, 2009-04, Vol.4 (4), p.e5401-e5401

2009

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of Radium‐223 dichloride combined with hormonal therapy for hormone receptor‐positive, bone‐dominant metastatic breast cancer

Cancer medicine (Malden, MA), 2020-02, Vol.9 (3), p.1025-1032

2020

Link zum Volltext

Verfügbarkeit prüfen

Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer Chemoprevention

European journal of breast health, 2023-10, Vol.19 (4), p.267-273

2023

Link zum Volltext

Verfügbarkeit prüfen

Histologic features of low- and intermediate-grade neuroendocrine carcinoma (typical and atypical carcinoid tumors) of the lung

Lung cancer (Amsterdam, Netherlands), 2011-01, Vol.71 (1), p.34-41

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 871

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(843)
Mit Volltextzugriff
(795)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(79)
Cancer Research
(30)
Clinical Cancer Research
(25)
Journal Of Pain And Symptom Management
(18)
Cancer
(17)
Blood
(11)
Genetics In Medicine
(11)
Nature
(11)
Cancer Prevention Research
(10)
Journal Of Ocular Pharmacology And Therapeutics
(10)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

KRAS Mutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer

Epidermal Growth Factor Receptor Copy Number Alterations Correlate With Poor Clinical Outcome in Patients With Head and Neck Squamous Cancer

Response to Neoadjuvant Systemic Therapy for Breast Cancer in BRCA Mutation Carriers and Noncarriers: A Single-Institution Experience

EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy

ETS2 Mediated Tumor Suppressive Function and MET Oncogene Inhibition in Human Non―Small Cell Lung Cancer

Adding Erlotinib to Chemoradiation Improves Overall Survival but Not Progression-Free Survival in Stage III Non-Small Cell Lung Cancer

miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1

Nomogram to Predict the Benefit of Radiation for Older Patients With Breast Cancer Treated With Conservative Surgery

A phase II study of talimogene laherparepvec for patients with inoperable locoregional recurrence of breast cancer

Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung

Frequency of Sarcopenia, Sarcopenic Obesity, and Changes in Physical Function in Surgical Oncology Patients Referred for Prehabilitation

Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer

Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination With the HER-1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib for Patients With Recurrent Non–Small-Cell Lung Cancer

Could Objective Tests Be Used to Measure Fatigue in Patients with Advanced Cancer?

A predictive probability design for phase II cancer clinical trials

Patients' Perspective of Timeliness and Usefulness of an Outpatient Supportive Care Referral at a Comprehensive Cancer Center

Abnormalities of the TITF-1 Lineage-Specific Oncogene in NSCLC: Implications in Lung Cancer Pathogenesis and Prognosis

CoxPhLb: An R Package for Analyzing Length Biased Data under Cox Model

Perioperative beta-blocker use and survival in lung cancer patients

Lack of PTEN Expression in Non-Small Cell Lung Cancer Could Be Related to Promoter Methylation

Bayesian clinical trials at the University of Texas M. D. Anderson Cancer Center

Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinoma

Phase II study of Radium‐223 dichloride combined with hormonal therapy for hormone receptor‐positive, bone‐dominant metastatic breast cancer

Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer Chemoprevention

Histologic features of low- and intermediate-grade neuroendocrine carcinoma (typical and atypical carcinoid tumors) of the lung

Suchergebnisse filtern